Streetbeat News

Stock Prices

BIDU

Financial analysts observed a bullish trend in Baidu's (NASDAQ:BIDU) options trading, with a significant portion of trades being calls over puts. The trading activity suggests a price target range between $50.0 and $120.0. Baidu, a dominant player in China's internet search market, has seen its stock price increase by 2.88%, with a current price of $97.79. The company is expected to announce earnings in 24 days, and a professional analyst from Citigroup has set a target price of $176.0, maintaining a Buy rating.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 5:45 pm

SOFI

Recent unusual options activity in SoFi Technologies (NASDAQ:SOFI) indicates a bearish sentiment among investors, with 63% of trades being bearish. The activity suggests an expected price range of $7.0 to $13.0 for SOFI over the next three months. The largest trades include both puts and calls, with a notable bearish put at a strike price of $13.00 expiring on 06/21/24. SoFi, a financial-services company, is expanding its offerings beyond student loan refinancing. The current market status shows SOFI's price at $7.21, with an upcoming earnings announcement. Analysts have issued mixed ratings with a consensus target price of $10.125.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 5:45 pm

MSFT

Microsoft Corp. (NYSE:MSFT) is set to report its fiscal Q3 2024 earnings with expectations of significant growth. Analysts predict earnings per share of $2.83 and revenue of $60.769 billion, marking a 15.1% year-on-year increase in revenue and a 15.98% increase in earnings. Goldman Sachs highlights Microsoft's unique position to scale Gen-AI revenue, projecting a +15% revenue growth and a 28% Azure growth. The firm maintains a 'Buy' rating on MSFT, with a 12-month price target of $450, indicating a strong investment opportunity.

Portfolio Pulse from Piero Cingari

April 22, 2024 | 5:40 pm

The Procter & Gamble Company (NYSE:PG) reported its fiscal third quarter financials, revealing a 1% increase in net sales to $20.20 billion, missing the expected $20.41 billion. However, net income rose 11% YoY to $3.75 billion, surpassing the estimate of $1.41 per share. Despite no price hikes in the quarter, prices were up 3% YoY. Organic sales expanded 3% YoY, but volume growth remained flat for the second consecutive quarter. P&G's beauty, grooming, and fabric and home business segments saw volume growth, while health care and baby, along with feminine and family care segments, saw declines. The company raised its full-year core net earnings per share growth forecast to 10-11% and maintained its sales growth forecast at 2-4%.

Portfolio Pulse from Upwallstreet

April 22, 2024 | 5:39 pm

NKGN

NKGen Biotech Inc (NASDAQ:NKGN) shares surged by 29.30% to $1.43 on Monday with a trading volume of 19.25 million, significantly higher than its 100-day average of 2.85 million. The increase comes without specific news to justify the price jump. The company is preparing to present its NK cell therapy developments for neurodegenerative diseases at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit. Earlier, NKGen Biotech secured $5 million in second-lien convertible loan funding, contributing to a total of approximately $4.75 million in gross cash proceeds for 2024. CEO Paul Song highlighted the company's focus on Phase 2 Alzheimer's clinical trials, a recent IND submission for Parkinson's disease, and a nearly 50% reduction in monthly operational and clinical trial expenses.

Portfolio Pulse from Vandana Singh

April 22, 2024 | 5:38 pm

AFRM

AXP

BAC

COIN

FOUR

Today's whale activity in the financials sector shows significant options trading across various stocks, indicating bullish, bearish, and neutral sentiments. Notable trades include bullish calls on BAC, C, COIN, AFRM, and GS, a bearish call on BX, bearish puts on FOUR, neutral trades on MA and V, and a bullish put on AXP. These activities suggest varying investor expectations and could influence short-term stock movements.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 5:35 pm

AMZN

DKNG

SBUX

TSLA

Today's session highlighted significant options activity for 10 consumer discretionary stocks, indicating varying sentiments among traders. Notable movements include bearish puts on TSLA and SBUX, bullish calls on DKNG and W, and a mix of sentiments on others like AMZN and F. This activity, tracked by Benzinga's options scanner, suggests traders are actively seeking opportunities based on market anomalies and whale transactions.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 5:35 pm

MARA

MCHP

MSFT

NVDA

ORCL

PLTR

RIOT

SMCI

SNOW

TSM

Today's whale activity in the Information Technology sector highlighted unusual options trading for several companies, indicating varying sentiments. Notable activities include bearish call option sweeps for NVDA and ORCL, bullish calls for TSM, MCHP, MARA, and SNOW, and neutral positions for SMCI and MSFT. These movements suggest significant market interest and potential shifts in stock prices based on the options' sentiments and volumes.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 5:35 pm

WGS

BTIG analyst Mark Massaro maintains a Buy rating on GeneDx Holdings (NASDAQ:WGS) and raises the price target from $11 to $15, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 5:34 pm

FuzzyPanda, a known short seller, has announced on X (formerly Twitter) that they continue to hold a short position in Globe Life Inc. ($GL), indicating ongoing bearish sentiment towards the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 5:32 pm